This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Oliver R. Thiel
Introduction
Oliver R. Thiel is an accomplished inventor based in Thousand Oaks, California. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has led to advancements that benefit both the scientific community and the healthcare industry.
Latest Patents
Oliver R. Thiel holds a patent titled "Method of Conjugation of Cys-MAbs." This patent represents a novel approach in the conjugation of cysteine-containing monoclonal antibodies, which can enhance their therapeutic efficacy. He has 1 patent to his name, showcasing his innovative contributions to the field.
Career Highlights
Thiel is currently employed at Amgen Inc., a leading biotechnology company known for its focus on human therapeutics. His role at Amgen allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
One of his notable collaborators is Dante Romanini. Together, they have worked on various projects that leverage their combined expertise in biotechnology and pharmaceutical development.
Conclusion
Oliver R. Thiel's contributions to the field of biotechnology, particularly through his patent and work at Amgen, highlight his role as an influential inventor. His innovative methods continue to pave the way for advancements in medical science.